Innoviva Stock Just This: Why a Fund Bought $2.5M More
A boutique fund recently boosted its Innoviva stake by $2.5 million, raising questions about the stock's modest 10% g...
Knowing when to revise your retirement strategy is key to staying on track. Learn the indicators that signal it's time for an adjustment.
21,255 articlesA boutique fund recently boosted its Innoviva stake by $2.5 million, raising questions about the stock's modest 10% g...
Two very different players dominate the modern financial scene: Ally Financial builds on auto lending with a growing ...
D-Wave Quantum stock swung wildly on momentum and policy headlines, then reversed hard. This guide breaks down what h...
Memory markets are shifting as mega-capex from Hynix and Samsung could ease shortages. Here's what that means for Mic...
In a market chasing AI hype, two heavyweight tech names stand out as compelling bargains. This article explains why N...
Investing in AI can feel like riding a hype wave. This article digs into what makes a stock a true money-maker, unvei...
Chime stock down since its June IPO has traders weighing risk and opportunity. A new $11 million stake from a promine...
The market recently pulled back from UPS gains, but a dip can signal opportunity for patient investors. This guide la...
Insider activity often sparks debate among investors. This article breaks down AXT's sold shares worth $1.41 million ...
TJX delivered a solid quarter, lifting confidence in a consumer-driven recovery. This analysis dives into whether com...
As the gig economy matures, two tech leaders stand out: Uber Technologies and DoorDash. This guide breaks down which ...
Palantir has seen a sizable pullback, but the real question for patient AI investors is whether this move creates a d...